This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Na Vaccine Institute, Seoul National University. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Ye Jin Jang - Innovator in Influenza Vaccine Development
Introduction
Ye Jin Jang is a prominent inventor based in Daejeon, South Korea. She has made significant contributions to the field of vaccine development, particularly in the area of influenza. Her innovative work has the potential to enhance public health and improve vaccine efficacy.
Latest Patents
Ye Jin Jang holds a patent for an "Influenza Vaccine Composition Based on Novel Nucleic Acid." This patent represents a breakthrough in the development of more effective influenza vaccines, showcasing her commitment to advancing medical science.
Career Highlights
Jang is affiliated with the Na Vaccine Institute, where she collaborates with other researchers to push the boundaries of vaccine technology. Her work is characterized by a focus on innovative solutions to combat infectious diseases.
Collaborations
She has worked alongside notable colleagues, including Eui Ho Kim and Myung Soo Kang. These collaborations have fostered a dynamic research environment that encourages the exchange of ideas and expertise.
Conclusion
Ye Jin Jang's contributions to vaccine development, particularly her patented work on influenza vaccines, highlight her role as a key innovator in the field. Her dedication to research and collaboration continues to pave the way for advancements in public health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
